Password reset request
  • Portal do Governo Brasileiro
  • Atualize sua Barra de Governo
  • Go to main content [1]
  • Go to main menu [2]
  • Enable hight contrast [3]
English Português Español
  • Sign in
    Forgot my password
> About  >
-
-
-
-
-
 
 

About ReBEC


ReBEC is publicly-owned, managed by the Oswaldo Cruz Foundation, a research organization in government and nonprofit organizations. All details of the studies reported in ReBEC are publicly available. According to resolution of ANVISA - RDC 36, of 27 June 2012 amending RDC 39/2008, all clinical phases I, II, III and IV, must show proof of registration of clinical research in the database Brazilian Registry of Clinical Trials - ReBEC, or proof of submission. For cases prior to publication of this resolution will be accepted proof of registration of the researches that have already been recorded in other primary records of the International Clinical Trials Registration Platform (ICTRP / WHO). For every record there is no cost. The required fields of ReBEC meet the minimum data set required by the International Committee of Medical Journal Editors (ICMJE) and the World Health Organization (WHO). After review and at the time of publication of the study in ReBEC website, the study receives a unique registration number. The responsibility for recording and reporting of studies is the sponsor. The test data will not be removed after they are posted. The result of a joint effort of the Ministry of Health (DECIT/MS), Institute of Communication and Information Science and Technology in Health (Icict/Fiocruz), the Pan American Health Organization (PAHO) and the Latin American and Caribbean Center on Health Sciences (Bireme), the ReBEC increases the effectiveness of efforts to disclose clinical trial studies public way, reducing publication bias. Thus, the ReBEC becomes an important source of information for patients, health professionals, researchers, companies and research centers, providing greater interaction and international integration. Institutional - Coordination Dr. Josue Laguardia
Senior Research Consultant
Dr Luiza Silva Coordinator Fundação Oswaldo Cruz
Instituto de Comunicação e Informação Científica e Tecnológica em Saúde – Icict
Av. Brasil, 4036 - Office Building Expansion - Room 807
Zip Code: 21040-361 - Rio de Janeiro, RJ - Brazil

Phone: +55(21)3882-9227
E-mail: rebec@icict.fiocruz.br
 
Approved trials

07/31/2026
How Brain Light Therapy Can Help People with Parkinson's Walk Better and Stay Balanced
 
07/31/2026
Vancomycin dosing in the bloodstream: trough-based method versus Area Under the Curve/Minimum Inhibitory Concentration-guided dosing and the risk of acute kidney injury a clinical study and meta-analysis.
 
07/31/2026
Use of essential oils for tooth grinding in children with congenital zika virus syndrome
 
07/31/2026
Exercise and kidney health in high school students
 
07/31/2026
Using telemedicine and new technologies to improve heart failure treatment
 
07/31/2026
Effect of Infrared Light on Chronic Renal patients undergoing hemodialysis and conservative treatment
 
07/31/2026
Effect of aromatherapy with lavender and orange essential oils on pain and anxiety management in patients undergoing lower third molar extraction
 

Total de Ensaios Clínicos 18676.

Existem 9537 ensaios clínicos registrados.

Existem 5157 ensaios clínicos recrutando.

Existem 67 ensaios clínicos em análise.

Existem 6195 ensaios clínicos em rascunho.

cadastre um novo usuário

notícias

sobre

painel de dados

ajuda

contato

equipe

links úteis

glossário